Dr. Juan P. Loy

Internal Medicine
2964 N State Rd, 7 Suite 210, 
Margate, FL 
Accepting New Patients
Offers Telehealth
2964 N State Rd, 7 Suite 210, 
Margate, FL 
OverviewInsuranceLocationsClinical Research

Overview

Juan Loy is an Internal Medicine provider in Margate, Florida. His top areas of expertise are Type 2 Diabetes (T2D), Familial Hypertriglyceridemia, High Cholesterol, and Osteomyelitis in Children. Dr. Loy is currently accepting new patients.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in FL
Languages Spoken
English
Mandarin
Spanish
Vietnamese
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  AvMed
  •  Blue Cross Blue Shield
  •  Aetna
  •  Health Options
  •  UnitedHealthcare
View 3 More Insurances +

Locations

2964 N State Rd, 7 Suite 210, Margate, FL 33063
Other Locations
5901 Colonial Dr, Suite 102, Margate, FL 33063

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo and Dulaglutide in Participants With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drugs: LY3437943, Dulaglutide
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses Versus Placebo in Patients With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone
Enrollment Status: Completed
Publish Date: October 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
29
conditions
Dr. Douglas M. Whitmore
Internal Medicine
Expertise in
29
conditions
Dr. Douglas M. Whitmore
Internal Medicine
1930 Ne 47th St, Suite 205, 
Ft Lauderdale, FL 
 (5.3 mi)
954-491-8981
Languages Spoken:
English
See accepted insurances

Douglas Whitmore is an Internal Medicine provider in Ft Lauderdale, Florida. Dr. Whitmore is highly rated in 29 conditions, according to our data. His top areas of expertise are Asthma in Children, Asthma, Lung Metastases, and Grass Allergy.

Expertise in
49
conditions
Dr. Alexis S. Guerra
Internal Medicine
Expertise in
49
conditions
Dr. Alexis S. Guerra
Internal Medicine

First Docs PC

830 Lakeside Cir, 
Pompano Beach, FL 
 (5.9 mi)
609-585-1122
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alexis Guerra is an Internal Medicine provider in Pompano Beach, Florida. Dr. Guerra has been practicing medicine for over 43 years is highly rated in 49 conditions, according to our data. His top areas of expertise are Necrosis, Atypical Pneumonia, Hospital-Acquired Pneumonia, Gastrostomy, and Prostatectomy. Dr. Guerra is currently accepting new patients.

Expertise in
62
conditions
Dr. Hamidreza H. Moghaddam
Internal Medicine
Expertise in
62
conditions
Dr. Hamidreza H. Moghaddam
Internal Medicine
1859 Van Buren St, 
Hollywood, FL 
 (11.2 mi)
954-920-9000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Hamidreza Moghaddam is an Internal Medicine provider in Hollywood, Florida. Dr. Moghaddam is highly rated in 62 conditions, according to our data. His top areas of expertise are Necrosis, Sepsis, Peptic Ulcer, Gastrostomy, and Endoscopy. Dr. Moghaddam is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile